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A comparison of the pathological proﬁles of two spongiform encephalopathies with a similar
presumptive route of infection was performed. Archival kuru and recent variant Creutzfeldt–Jakob
disease (vCJD) cases reveal distinct lesional differences, particularly with respect to prion protein,
suggesting that the strain of agent is important in determining the phenotype. Genotype analysis of
the polymorphism on codon 129 reveals (in conjunction with updated information from more kuru
cases) that all three genotypes (VV, MV and MM (where M is methionine and V is valine)) are
detected in kuru with some preference for MM homozygosity. The presence of valine does not
therefore appear to determine peripheral selection of PrP
CJD. vCJD remains restricted to date to MM
homozygosity on codon 129. It remains to be determined whether this genotype is dictating a shorter
incubation period.
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McLean et al.( 1 9 9 8 )reviewed 11 archival cases of kuru
held in the University of Melbourne. A comparative
studyofthepathologyandthehostgenotype,particularly
the naturally occurring (‘public’) polymorphism on
codon 129, was conducted using these kuru cases and
11 new variant Creutzfeldt–Jakob disease (vCJD) cases
from the UK. The triad of spongiform change, neuronal
lossandgliosiswasseeninallkurucasesinadistribution
similar to that originally described, with prominent
involvement of all cortical areas with the exception of
the occipital cortex, hippocampus and insular gyri, and
prominent changes also seen in the putamen, caudate
and cerebellar cortex (ﬁgure 1; Fowler & Robertson
1958; Klatzo et al.1 9 5 9 ; Neumann et al. 1964; Kakulas
et al.1 9 6 7 ; Beck & Daniel 1979).
Neuropathological comparison of vCJD and kuru
revealed that these diseases show distinct differences,
particularly with PrP
CJD immunohistochemistry, where
there was a much greater PrP load in all brain areas in
vCJD than in kuru, with the exception of the cerebellar
granular layer (table 1). The patterns of immunohisto-
chemical changes in the brain also varied between vCJD
and kuru (table 2). A comparison of the phenotype of
kuru with more recent subtyping of Creutzfeldt–Jakob
disease (CJD) shows that the kuru cases resemble those
cases of sporadic CJD with type 2 PrP
CJD (Parchi et al.
1996). McLean et al. (1998) reported immunoperox-
idase studies using the antibody 3F4 (SIGNET).
A review of selected cases in 2008 using 12F10
(no. 189710 Cayman Chemical) highlights stronger
and more pronounced reactivity (ﬁgure 2) than with the
original 3F4immunoperoxidase studies reported earlier.
The underlying differences in neuropathological
proﬁles were thought to be in keeping with the different
clinical features in these two disorders. Although both
diseases exhibit prominent cerebellar ataxia, vCJD
lacks the chronic emotional lability characteristic of
kuru, and is characterized instead by psychiatric and
sensory symptoms at onset with subsequent myoclonus
and other movement disorders followed by dementia
and akinetic mutism (Will et al. 1996).
The 11 cases of kuru showed a homogeneous
pattern of prion protein deposition with an accentua-
tion of cerebellar changes. Of the ﬁve cases in which the
codon 129 could be assessed, there were two MM and
three VV genotypes (M, methionine; V, valine; McLean
et al. 1998). Analyses of codon 129 in kuru have shown
that those patients with an MM genotype were
preferentially affected and those with MV and VV
genotypes appeared to be predisposed to a lower risk of
disease development and longer incubation times
(Cervena ´kova ´ et al. 1998; Lee et al. 2001; see also
Hainfellner et al. 1997; Lantos et al. 1997). Similarly,
Collinge et al. (2006), in a study of 11 identiﬁed
patients with kuru with assessabled incubation
periods of 39–56 years, found they were heterozygous
at the polymorphic codon 129 and believe this
genotype is associated with an extended incubation
period. The presence of MM homozygotes in kuru
a l s os u g g e s t st h a ti ti sn o tt h ep r e s e n c eo fv a l i n e1 2 9
that determines peripheral selection of the PrP
CJD,a s
previously postulated to account for the high
frequency of a valine 129 in other cases of iatrogenic
CJD (Collinge et al. 1996). In vCJD, all cases to date
have been MM homozygotes; however, vCJD has
occurred within a very limited time frame compared
with kuru (Cousens et al. 1997; Collinge et al. 2006).
It therefore remains to be determined whether
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incubation period in vCJD. Moreover, the prolonged
incubation period in kuru (over 50 years in some
cases) may be signiﬁcant when attempting to estimate
future numbers of vCJD.
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Table 1. PrP
CJD load assessed on a scale of C to CCC.
(Comparison of the PrP
CJD load in vCJD and kuru by
immunohistochemistry.)
PrP
CJD load vCJD kuru
frontal cortex CCC C
basal ganglia CCC C
thalamus CCC C
cerebellar molecular layer CCC C
cerebellar granular layer CCC CC–CCC
basis pontis CC C
spinal grey matter CC C
substantia gelatinosa CC
Table 2. PrP
CJDpatternseitherpresent(C)ornotpresent(K).
(Comparison of the PrP
CJD patterns in vCJD and kuru by
immunohistochemistry.)
PrP
CJD pattern vCJD kuru
ﬂorid plaques CK
linear/granular diffuse plaques CK
dendritic CC
perineuronal CC
cortical L3-5 laminar KC
accentuation
linear white matter in the brain stem
and the spinal cord
CC
granular intracytoplasmic CK
Figure 2. Kuru cerebellum showing strong immunoreaction
with a granular pattern and plaque deposit in the granular
layer and linear deposition within the molecular layer (12F10
prion protein, !400 actual magniﬁcation).
Figure 1. Kuru cerebellum showing spongiform change in the
molecular layer, neuronal loss (Purkinje cells and granular
cells) and gliosis (haematoxylin and eosin, !200 actual
magniﬁcation).
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